Navigation Links
Immune-Based Lymphoma Treatment Shows Promise
Date:5/31/2009

Similar patient-tailored approaches may work for skin, stomach and other cancers, researchers say

SUNDAY, May 31 (HealthDay News) -- In a new study, patients with follicular non-Hodgkin lymphoma who received a vaccine made from their own cancer cells went more than 44 months before relapsing, compared to only 30.6 months for those who didn't get the vaccine.

The vaccine trial was one of several studies from the new frontier of "personalized medicine" presented Sunday at the American Society of Clinical Oncology (ASCO) annual meeting, in Orlando, Fla.

The approach aims to hit cancer hard by tailoring treatments to the patient's own genetics or disease, among other factors.

The lymphoma study differs from other vaccine trials in that the tool was patient-specific, study author Dr. Stephen Schuster, an associate professor at the University of Pennsylvania School of Medicine, explained at a Sunday news conference.

The findings could signal a whole new direction in how vaccines are used against cancer, experts said.

"The novelty of the vaccines is that they were individualized to each patient, and that they were directed against a cancer-specific target," said Dr. Louis Weiner, director of Georgetown's Lombardi Comprehensive Cancer Center in Washington, D.C. "Many vaccines are directed against cancer-associated targets and always run the risk of damage to normal cells."

But the lymphoma vaccine is "almost like an immune-system 'smart bomb,'" Weiner noted. "It only goes after malignant cells, and that's very attractive."

For this phase III trial, 76 patients who had been in remission for at least six months following chemotherapy were injected with BiovaxID, a vaccine engineered from cancerous tissues drawn from each individual patient. The mixture also contained compounds designed to heighten the effect of the vaccine.

These individualized vaccines took about three mo
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4 5

Related medicine news :

1. Immune-based drug approved in Europe for pediatric cancer patients
2. The Leukemia & Lymphoma Society Hosts Workshop On Weighing Treatment Options For Chronic Myelogenous Leukemia
3. The Leukemia & Lymphoma Society Provides Patients with the Latest Information on Myeloma
4. Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008
5. January 1 Looms Large for Lymphoma Patients
6. Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkins Lymphoma Patients
7. Possible Cure for Rare Lymphoma Reported
8. Pharmion and Methylgene Report Favorable Results for Phase 2 MGCD0103 Single- Agent Studies in Relapsed or Refractory Lymphomas at the 49th American Society of Hematology (ASH) Meeting
9. Gentler chemotherapy before stem cell transplant causes long-term remission of follicular lymphoma
10. Genmab Initiates Ofatumumab Phase II Study in Diffuse Large B-Cell Lymphoma
11. Lymphoma drug used to treat skin disorders
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Immune-Based Lymphoma Treatment Shows Promise
(Date:7/31/2014)... AK (PRWEB) July 31, 2014 ... announced the hiring of new dentist Dr. Jonathan Oudin, ... Oudin had previously practiced in Barrow, Alaska, for three ... Center for Dentistry hired Dr. Oudin to help take ... Center for Dentistry to continue growing and serving the ...
(Date:7/31/2014)... July 31, 2014 (HealthDay News) -- With the World ... West African Ebola outbreak has risen to 729, ... Thursday issued a travel warning for,the region. The ... to the affected countries -- Guinea, Liberia and Sierra ... that Ebola is worsening in West Africa," CDC Director ...
(Date:7/31/2014)... of invasive lionfish causing fish poisoning may be unfounded. ... derbies and targeted fisheries may remain the best way ... to know for sure whether a lionfish is toxic: ... lionfish were first reported off the coast of Florida ... number ever since. They,re now found in marine habitats ...
(Date:7/31/2014)... Insight Accelerator Labs member PhysIQ (formerly ... of investment for $4.6 million to fund the continued ... signs. The company joined Insight Accelerator Labs in ... the help of Insight development teams. , ... the Accelerator,” says Steve McPhilliamy, Executive Director of Insight ...
(Date:7/31/2014)... July 31, 2014 Women in the ... charge of their financial future. The Independent Woman ... opened registration for 6 upcoming Los Angeles area events. ... women, and with input from Kim Kiyosaki, a successful ... Rising Time) who is passionate about women’s financial education. ...
Breaking Medicine News(10 mins):Health News:Dr. Jonathan Oudin to Join Alaska Center for Dentistry at Wasilla Location 2Health News:CDC Issues Travel Warning as West Africa Ebola Outbreak Worsens 2Health News:Invasive lionfish likely safe to eat after all 2Health News:Invasive lionfish likely safe to eat after all 3Health News:Insight Accelerator Labs Advances Member Toward Commercialization 2Health News:Insight Accelerator Labs Advances Member Toward Commercialization 3Health News:The Independent Woman to Offer Financial Workshops in the Los Angeles Area - Developed by Women for Women 2
... study says that people with low birth weight may ... diet and controlling their body weights. ,Diabetes affects ... blood glucose and impaired function of the insulin that ... risk factors for diabetes are obesity, physical inactivity, genetic ...
... Researchers from University of Liverpool had proposed that patients ... from medication. They say that it is advisable to ... ,Researchers of the study feel that early treatment in ... a better quality of life with epilepsy. They have ...
... suggested that obesity,in middle age increases the risk ... progressive,brain dysfunction that occurs most commonly late in,life. ... activities. ,The 27 year longitudinal study that ... data from a population of around 10276,males and ...
... interesting prospective study undertaken by the,researchers at Massachusetts General ... that ,higher intake of low-fat dairy may lower the ... type 2 diabetes, either the body does not produce,enough ... for the body to be able to use,sugar. Type ...
... patients with highly active antiretroviral treatment (HAART) needs ... says researchers from Belgium. ,Highly active antiretroviral ... HIV/AIDS patient’s life expectancy. This is especially helpful ... patients will have to have a full commitment ...
... procedure to do laproscopic esophagectomy on patients who suffers// ... esophagus. ,Currently to test the extent of damage ... called laproscopic esophagectomy. In this process the surgeons had ... the patients to insert fiber optic instruments to be ...
Cached Medicine News:
(Date:7/31/2014)... SAN DIEGO , July 31, 2014  Sorrento Therapeutics, ... death of Mr. Amar Singh , Chief Business Officer ... of apparent natural causes on July 30. "Sorrento ... dear friend and colleague. Our immediate thoughts go to Amar,s ... President and Chief Executive Officer. Mr. Singh ...
(Date:7/31/2014)... Diabetes Care®, Inc. (NASDAQ: TNDM ), a medical ... reported its financial results for the quarter ended June 30, ... 2014 to the same period of 2013: , Sales ... , t:slim Pump shipments grew 64 percent to 2,235 pumps ... June 30, 2014 to the same period of 2013: ...
(Date:7/31/2014)... July 31, 2014 Nektar Therapeutics (Nasdaq: ... quarter ended June 30, 2014. Cash and ... million as compared to $309.1 million at March 31, 2014."The ... Nektar as we look forward to significant milestones for a ... President and Chief Executive Officer of Nektar. "The first of ...
Breaking Medicine Technology:Sorrento Announces the Unexpected Death of its Chief Business Officer 2Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 2Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 3Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 4Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 5Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 6Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 2Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 3Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 4Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 5Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 6Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 7Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 8Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 9Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 10Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 11Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 12Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 13Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 14
... The Oklahoma Bureau of Narcotics (OBN) is partnering ... owner/operator of the Energy-from-Waste facility in Tulsa to safely ... March 1, 2011, through the Safe Trip for Scripts ... disposal metal containers in police and sheriff department lobbies ...
... CryoLife, Inc. (NYSE: CRY ), a ... and vascular surgery, announced today its results for the second ... second quarter were a record $29.4 million compared to $29.3 ... first six months increased to a record of $59.6 million ...
Cached Medicine Technology:Narcotics Bureau Partners With Covanta Energy and the City of Tulsa for Safe Prescription Drug Disposal 2Narcotics Bureau Partners With Covanta Energy and the City of Tulsa for Safe Prescription Drug Disposal 3CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 2CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 3CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 4CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 5CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 6CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 7CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 8CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 9CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 10CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 11CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 12CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 13CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 14CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 15CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 16CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 17CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011 18
All welded construction for strength and durability. Choice of stainless steel or chrome plated models....
Ideal for surgical procedures, these portable stands fit into tight areas for easy instrument access. Easy placement over patient....
Fixed chair back and armrests, electric lift with 8" (20.3cm) stroke, foot pedal control, choice of upholstery colors. Optional features: 15 tilt mechanism and footrest, locking rotation, sliding arm...
... HPX Streak Retinoscope comes ... and provides 40% more ... scopes and maintains a ... greatly enhances illumination and ...
Medicine Products: